Clinical Trial Update: Allo After Allo Stem Cell Transplantation Following Relapse After Allogeneic Transplant in Haematological Malignancies: Retrospective Results of the GETH

View source ↗

Summary

Retrospective results from the GETH examine outcomes of performing another allogeneic stem cell transplantation in patients with hematologic malignancies who re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematologic Malignancies

Snippet

Sponsor: Grupo Espanol de trasplantes hematopoyeticos y terapia celular | Conditions: Allogeneic Stem Cell Transplantation | Status: UNKNOWN